Oliver Wyman, a subsidiary of Marsh & McLennan Companies Inc., has announced its agreement to acquire Validate Health, a healthcare analytics business. This acquisition is set to bolster Oliver Wyman Actuarial by integrating advanced analytic and technology solutions that aid healthcare providers and Accountable Care Organizations in managing costs, risk, and performance. The transaction, expected to close in summer 2025, aims to enhance client services, improve market growth, and optimize healthcare programs, ultimately benefiting patient outcomes. Andrew Webster, Co-Founder of Validate Health, expressed optimism about the partnership, highlighting the potential to advance their mission of improving healthcare through data.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。